TN HB1419 | 2023-2024 | 113th General Assembly
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on January 31 2023 - 25% progression, died in chamber
Action: 2023-02-07 - Assigned to s/c Health Subcommittee
Text: Latest bill text (Draft #2) [PDF]
Status: Introduced on January 31 2023 - 25% progression, died in chamber
Action: 2023-02-07 - Assigned to s/c Health Subcommittee
Text: Latest bill text (Draft #2) [PDF]
Summary
As introduced, prohibits a healthcare prescriber from issuing a prescription for a dual-purpose prescription medication for diabetes to a person in this state if the person does not have a diagnosis of diabetes; defines a dual-purpose prescription medication for diabetes as a prescription drug that has a listed indication for diabetes and may also be used for purposes of weight loss in persons who do not have a diagnosis of diabetes. - Amends TCA Title 53; Title 56; Title 63; Title 68 and Title 71.
Title
AN ACT to amend Tennessee Code Annotated, Title 53; Title 56; Title 63; Title 68 and Title 71, relative to medications intended for persons with diabetes.
Sponsors
Rep. Ed Butler [R] |
History
Date | Chamber | Action |
---|---|---|
2023-02-07 | House | Assigned to s/c Health Subcommittee |
2023-02-02 | House | P2C, ref. to Health Committee |
2023-02-01 | House | Intro., P1C. |
2023-01-31 | House | Filed for introduction |
Same As/Similar To
SB1314 (Crossfiled) 2023-02-06 - Passed on Second Consideration, refer to Senate Commerce and Labor Committee